Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-center, Randomized, Double-blind, Parallel, Placebo Controlled Phase II Study to Evaluate the Efficacy and Safety of Fugan Ointment (ZL-3101) in Subjects With Subacute Eczema

NCT03134352 is registered in ClinicalTrials.gov with Zai Lab Pty. Ltd. as lead sponsor.

NCT NCT03134352
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03134352 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-center, Randomized, Double-blind, Parallel, Placebo Controlled Phase II Study to Evaluate the Efficacy and Safety of Fugan Ointment (ZL-3101) in Subjects With Subacute Eczema
Lead sponsor
Zai Lab Pty. Ltd.
Phase
Phase 2
Overall status
Completed
Start date
April 26, 2017
Completion date
September 10, 2018
Enrollment
290 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

eczema